3 STIM: Prospective Multicentric Study Comparing the Acute Hemodynamic Effect of Three Modes of Stimulation in Cardiac Resynchronization Therapy Recipients

Sponsor
CMC Ambroise Paré (Other)
Overall Status
Terminated
CT.gov ID
NCT03779802
Collaborator
(none)
50
3
1
11.9
16.7
1.4

Study Details

Study Description

Brief Summary

Cardiac Resynchronization Therapy (CRT) is an established treatment for patients with systolic heart failure and bundle branch block, improving functional capacity, quality of life and reducing morbi-mortality.

Adjusting atrio-ventricular (AV) delay, vector optimization and choice of different modes of stimulation can influence the acute hemodynamical consequences of CRT but also its medium-term and long-term clinical and echocardiographic effects.

The aim of the present prospective study is to investigate whether the different stimulation modes lead to different acute hemodynamic response, by evaluating the highest systolic pressure using the Finapress ® method.

Condition or Disease Intervention/Treatment Phase
  • Other: Device programming of ABBOTT CRT pacemaker or defibrillator
N/A

Detailed Description

This study is a non-randomized, prospective, interventional, multicentric study.

Patients implanted with an Abbott ® CRT pacemaker or defibrillator since less than 3 months are eligible for the study.

Recruited patients will be submitted to a non-invasive evaluation of different pacing modes. This will be performed using the Finapress NOVA device, which records blood pressure with a digital cuff. The peak of blood pressure will correspond to the optimal device settings

Three modes of stimulation of ABBOTT CRT devices will be compared:
  • Classical bi-ventricular pacing mode at nominal value and with AV delay optimization

  • SyncAV mode at nominal value or with left ventricular preexcitation optimization

  • Multipoint Pacing (MPP) mode, alone or in combination with SyncAV mode This is an acute evaluation study without scheduled follow-up.

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of the Acute Hemodynamic Effect of Three Modes of Stimulation in Cardiac Resynchronization.
Actual Study Start Date :
Apr 23, 2019
Actual Primary Completion Date :
Apr 18, 2020
Actual Study Completion Date :
Apr 18, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: CRT device

Patients implanted with a CRT device who will undergo a non-invasive hemodynamic evaluation of different pacing modes

Other: Device programming of ABBOTT CRT pacemaker or defibrillator
Comparison of the acute hemodynamic effect of three modes of stimulation in ABBOTT CRT devices (Biventricular, SyncAV and MPP modes) by using the Finapress® NOVA method to assess the highest systolic blood pressure (SBP) during the programming session Comparison of the acute hemodynamic effect of three modes of stimulation in ABBOTT CRT devices (Biventricular, SyncAV and MPP modes) by using the Finapress® NOVA method to assess the highest systolic blood pressure (SBP) during the programming session.

Outcome Measures

Primary Outcome Measures

  1. Hemodynamic response [day 0]

    Highest Systolic Blood Pressure (SBP) obtained by optimization of the mode of stimulation

Secondary Outcome Measures

  1. Other hemodynamical response [day 0]

    Cardiac output

  2. Other hemodynamical response [day 0]

    Systolic ejection volume

  3. Other hemodynamical response [day 0]

    dP/dT

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient older than 18

  • Implantation of a CRT (CRT-P or CRT-D) less than 3 months before inclusion

  • MPP and SyncAV-enabled ABBOTT Quadripolar CRT pacing system

  • Patient who had signed an informed consent and is willing to comply with study requirements

  • De novo implantation

  • Patient covered by national healthcare insurance

Exclusion Criteria:
  • Permanent/persistant atrial fibrillation/ supra-ventricular tachycardia

  • Pacing indication for 2nd or 3rd degree AV block

  • Upgrading from non-CRT system

  • Pregnant or breastfeeding women

  • Adult under legal protection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gehm Site D'Eaubonne Eaubonne Val-d'Oise France 95600
2 Cmc Ambroise Pare Neuilly sur seine France 92200
3 CHU Poitiers Poitiers France

Sponsors and Collaborators

  • CMC Ambroise Paré

Investigators

  • Principal Investigator: Ghassan MD MOUBARAK, CMC Ambroise Paré

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
CMC Ambroise Paré
ClinicalTrials.gov Identifier:
NCT03779802
Other Study ID Numbers:
  • 2018/10
First Posted:
Dec 19, 2018
Last Update Posted:
May 22, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by CMC Ambroise Paré
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 22, 2020